Blood work for suspected poison hemlock (Conium maculatum) poisoning
Order a focused tox/rhabdo/respiratory-failure panel immediately: BMP, Mg, Ca, phosphorus; CK; serum/urine myoglobin; VBG/ABG with co-oximetry; lactate; CBC; LFTs; urinalysis; and ECG, with serial CK/creatinine and electrolytes q6–8h for 24–48h. This prioritizes early detection of respiratory acidosis, hyperkalemia, rhabdomyolysis, and acute kidney injury—key drivers of morbidity, mortality, and quality of life in hemlock poisoning. In parallel, send toxicology confirmation for coniine if available, but do not delay supportive care awaiting results 1, 2, 3, 4.
Rationale and evidence strength
- Highest-priority outcomes are respiratory failure, rhabdomyolysis, hyperkalemia, and AKI. Human series show frequent rhabdomyolysis with some progressing to biopsy-proven acute tubular necrosis; mortality is driven by paralysis/respiratory arrest and renal complications 1. Contemporary reviews echo neurotoxicity → paralysis, rhabdo, and AKI, with good survival if promptly supported 2, 4.
- Analytical confirmation of coniine is feasible (GC/MS or LC-MS/MS on blood/urine/gastric content) but typically reference-lab and post hoc; it should not delay life-saving monitoring/intervention 3.
- No hemlock-specific guideline exists; thus, real-world care should mirror toxic/caustic and tox-neuromuscular guidelines that emphasize early labs for acidosis, lactate, end-organ injury, and serial trends to predict poor outcomes 5.
Algorithmic order set (stat unless noted)
Airway/ventilation risk
- ABG or VBG with co-oximetry (PaCO2, pH, SaO2, lactate); repeat per status. Detect hypoventilation and lactic acidosis from hypoxia/shock 5.
- Continuous pulse oximetry and capnography if available.
Rhabdomyolysis and renal injury
- CK (stat; then q6–8h until downtrend).
- Serum/urine myoglobin.
- BMP: Na, K, Cl, HCO3, BUN, creatinine, glucose; add Mg, Ca, phosphorus. Trend q6–8h for 24–48h; treat hyperkalemia early to prevent malignant arrhythmias 1.
- Urinalysis (heme without RBCs suggests myoglobinuria).
Systemic injury/sepsis mimic screen
- CBC with differential; LFTs; serum lactate. Abnormalities correlate with worse outcomes in caustic/toxic ingestions and guide escalation 5.
Cardiorespiratory safety
- 12-lead ECG (baseline and with electrolyte changes) to detect K+-related arrhythmias.
Confirmation (do not delay care)
- Toxicology for hemlock alkaloids:
- Standard urine drug screen is low yield; order only if alternate/combined tox is suspected.
Ongoing monitoring
- Repeat BMP (with K+, creatinine, bicarbonate), CK, and ABG/VBG q6–8h initially; extend interval once improving.
- Strict I/O; consider Foley for output targeting in rhabdomyolysis.
Nuances, pitfalls, and how to avoid them
- Pitfall: Waiting for coniine confirmation. Avoid delays; manage airway/ventilation and rhabdomyolysis immediately—these drive mortality 1, 2.
- Pitfall: Missing early rhabdomyolysis. Always send CK and urine myoglobin on presentation and trend frequently; renal failure may follow quickly 1.
- Pitfall: Under-monitoring potassium and bicarbonate. Serial electrolytes and ECG are mandatory; treat hyperkalemia aggressively to prevent fatal arrhythmias 1.
- Pitfall: Overreliance on standard tox screens. Coniine is not on routine panels; send specific GC/MS or LC-MS/MS where feasible but treat first 3.
- Pitfall: Assuming normal initial labs exclude severe injury. Kinetics matter; repeat testing improves detection of evolving necrosis/organ injury in toxic ingestions 5.
When to escalate
- Rising CK >5,000–10,000 U/L, K+ ≥6.0 mmol/L, worsening acidosis, or rising creatinine: initiate aggressive IV fluids, electrolyte management, consider bicarbonate/urine alkalinization per rhabdomyolysis protocols; involve nephrology early for possible RRT—these steps reduce morbidity and mortality 1.
- Any signs of hypoventilation or bulbar weakness: early airway management to prevent arrest—primary determinant of survival and neurologic QOL 2, 4.